Findings from the phase 2 DOREMY trial.
Diagnosis, treatment, funding are all greatly affected.
The treatment will be available under the Cancer Drugs Fund
Physicians are again discussing hospice care with patients.
Rapid, durable responses seen especially in high-grade gliomas.
Adjusting for site and stage eliminate the link between chemotherapy and stroke.
The test identifies tissue of origin too.
Cancer patients may be at high risk for complications, especially those with lymphopenia, neutropenia.
Findings from Wuhan, China, suggest aggressive measures to curtail frequency of hospital visits.
First clinical trial to use sham acupuncture as a second control group.
Strategies to better tailor effective treatments are needed.
Bisphosphonates, denosumab are preferred.
Early assessment, support important for patients older than 50 years.
Olaratumab is no longer recommended as first-line treatment.
Consider alternative treatment options to olaratumab since available stock will expire by April 2020.
Can legalization help counteract the opioid crisis?
By activating the bacterial SOS response, chemotherapy treatments promote antibiotic resistance and bacterial translocation.
